A Longitudinal Quantitative Assessment of the Effectiveness of Metatarsal Pads on Plantar Pressures

April 26, 2021 updated by: University Health Network, Toronto
Musculoskeletal deformities of the foot and abnormal biomechanics can create areas of high pressure over bony prominences on the plantar aspect of the foot and often lead to the formation of calluses and corns. Calluses and corns are reported to be the most prevalent foot conditions affecting peoples' lifestyles due to pain and disability. Redistribution of plantar pressure away from areas of high pressure offloading using felt pads to treat corns and calluses is a common practice in chiropody. A more comprehensive understanding of how rapidly the felt pads compress and become less effective in offloading pressure is needed to design better treatment plans to manage calluses and corns and improve patients' quality of life. The objectives of this study are: 1) develop a guideline which informs, at what duration (number of weeks) the semi compressed felt (SCF) Plantar Metatarsal Pad (PMP) should be replaced to manage plantar forefoot callus; 2) Test the guideline by replacing the SCF padding at the determined time interval. The study will be conducted at the Michener Chiropody Clinic at the Michener Institute of Education at UHN. In order to address patient selection bias, the investigators will be recruiting the first 25-40 participants presenting with forefoot callus who meet the inclusion criteria and consent to participate in the study. An exploratory, descriptive and analytic repeated measures study design will be used to address our research questions. The descriptive approach will provide insight into the nature of change over time in the dependent variables, pain and pressure, and an analytic approach will enable further insight into the relationship between those variables. The quantitative metrics used are average plantar pressure at the callus site, as well as self-reported pain using a Visual-Analog Scale (VAS). Results from the first phase will inform the development of the guideline for pad replacement, which in turn will be tested in the next phase of the study.

Study Overview

Status

Recruiting

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5T 1V4
        • Recruiting
        • Michener Chiropody Clinic
        • Contact:
        • Sub-Investigator:
          • Meera Narenthiran, DCH
        • Sub-Investigator:
          • Gayatri Aravind, PhD
        • Sub-Investigator:
          • Emily MacLeod, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

The participants to be studied are from the general population with callus on the plantar aspect of the forefoot. The participants must have appropriate footwear with adequate space for pads and must be agreeable to wearing them majority of the study period for weight bearing activities. Participants must be willing to attend clinic every two weeks for 8 weeks

Exclusion Criteria:

Participants with an active or past history of foot ulcers, those with Charcot neuroarthropathy as well as those who were unable to walk unaided will be excluded from the study. All participants will undergo a neuropathic assessment, including the vibration using a 127Hz tuning fork, protective sensation using a 10 gram monofilament and proprioception to exclude patients with neuropathy. Participants will be excluded if they have any foot skin disorders such as infections, dermatitis and psoriasis. Furthermore, anyone with neuropathy or diabetes for over 5 years will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Arm
Participants with forefoot callus will receive routine treatment of debridement of callus. Along with the debridement, a Plantar Metatarsal Pad (PMP) made of Semi-Compressed Felt (SCF) with appropriate cut outs will be placed in their shoes. The thickness of the SCF would be selected based on the patient weight, and appropriateness of the thickness would be confirmed by the Medilogic pressure measurement. A 50% pressure reduction is the desired outcome.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Average Plantar Pressure 0-8 weeks
Time Frame: Change from baseline to 8 weeks
The change in the average value of plantar pressure identified during the gait cycle from baseline to 8 weeks after the application of the semi-compressed felt pad.
Change from baseline to 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived pain
Time Frame: 0 (pre and post insertion of SCF), 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Self-reported levels of pain will be recorded using the Visual Analogue Scale (0-100)
0 (pre and post insertion of SCF), 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Physical Activity
Time Frame: 0 (pre and post insertion of SCF), 2 weeks, 4 weeks, 6 weeks, and 8 weeks
23 item questionnaire assessing the daily activity profiles of the participants.
0 (pre and post insertion of SCF), 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Sociodemographic data- employment
Time Frame: 0 (pre and post insertion of SCF), 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Location of place of employment - at home or outside of home
0 (pre and post insertion of SCF), 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Sociodemographic data - job description
Time Frame: 0 weeks
Brief description of job demands
0 weeks
Daily physical activity- workday sitting time
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Time spent sitting on a typical work day in hours
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Daily physical activity- weekend sitting time
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Time spent sitting on a typical weekend day in hours
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Daily physical activity- work day standing time
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Time spent standing on a typical work day in hours
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Daily physical activity- weekend standing time
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Time spent standing on a typical weekend day in hours
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Daily physical activity- workday walking time
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Time spent walking or running or climbing on a typical work day in hours
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Daily physical activity- weekend walking time
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Time spent walking or running or climbing on a typical weekend day in hours
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Daily physical activity- workday time spent on feet
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Category of time spent on feet in hours on a typical work day in hours
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Daily physical activity- weekend time spent on feet
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Category of time spent on feet in hours on a typical weekend day in hours
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Daily physical activity- workday strain on feet
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Category of foot strain experienced on a typical work day
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Daily physical activity- weekend strain on feet
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Category of foot strain experienced on a typical weekend day
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Daily physical activity- time of wearing pad on a workday
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Category of time for which pad was worn on a typical work day in hours
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Daily physical activity- time of wearing pad on a weekend day
Time Frame: 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Category of time for which pad was worn on a typical weekend day in hours
0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ann Russell, PhD, The Michener Institute for Education at UHN

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 6, 2020

Primary Completion (Anticipated)

May 31, 2021

Study Completion (Anticipated)

August 30, 2021

Study Registration Dates

First Submitted

February 24, 2020

First Submitted That Met QC Criteria

April 3, 2020

First Posted (Actual)

April 7, 2020

Study Record Updates

Last Update Posted (Actual)

April 28, 2021

Last Update Submitted That Met QC Criteria

April 26, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 18-5921

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Keratosis

3
Subscribe